ImmunityBio Strengthens Balance Sheet with $100 Million of Financing Transactions Including $75 Million of Non-Dilutive Financing to Support Global Expansion and Advancement of Broader Immunotherapy P
Go back to ImmunityBio Strengthens Balance Sheet with $100 Million of Financing Transactions Including $75 Million of Non-Dilutive Financing to Support Global Expansion and Advancement of Broader Immunotherapy P| (NASDAQ: IBRX) | Delayed: 7.32 +0.10 (1.39%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.22 | 52 Week High | $ | |||
| Open | $7.05 | 52 Week Low | $ | |||
| Day High | $7.60 | P/E | N/A | |||
| Day Low | $7.00 | EPS | $ | |||
| Volume | 11,307,314 | |||||
